{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:54:31Z","timestamp":1783515271665,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T00:00:00Z","timestamp":1713398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","atherosclerosis-journal.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.atherosclerosis.2024.117558","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T22:01:59Z","timestamp":1713391319000},"page":"117558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Impact of loss-of-function in angiopoietin-like 4 on the human phenome"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7483-1371","authenticated-orcid":false,"given":"Eloi","family":"Gagnon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Bourgault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9milie","family":"Gobeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Th\u00e9riault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit J.","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2024.117558_bib1","article-title":"Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism","volume":"62","author":"Kersten","year":"2021","journal-title":"JLR (J. Lipid Res.)"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117558_bib2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMoa1510926","article-title":"Inactivating variants in ANGPTL4 and risk of coronary artery disease","volume":"374","author":"Dewey","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117558_bib3","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1038\/s41467-018-04611-z","article-title":"Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes","volume":"9","author":"Gusarova","year":"2018","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.atherosclerosis.2024.117558_bib4","doi-asserted-by":"crossref","first-page":"13213","DOI":"10.1074\/jbc.M900553200","article-title":"Genetic variation in ANGPTL4 provides insights into protein processing and function","volume":"284","author":"Yin","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2024.117558_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12944-016-0231-6","article-title":"ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels and predicts cardiovascular disease risk in Type 2 diabetic Tunisian population","volume":"15","author":"Abid","year":"2016","journal-title":"Lipids Health Dis."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117558_bib6","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","article-title":"Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease","volume":"374","author":"Stitziel","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2024.117558_bib7","article-title":"CoPheScan: phenome-wide association studies accounting for linkage disequilibrium","author":"Manipur","year":"2023","journal-title":"Genetics"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117558_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117558_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cmet.2021.01.001","article-title":"A regulatory variant at 3q21.1 confers an increased pleiotropic risk for hyperglycemia and altered bone mineral density","volume":"33","author":"Sinnott-Armstrong","year":"2021","journal-title":"Cell Metabol."},{"issue":"7890","key":"10.1016\/j.atherosclerosis.2024.117558_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41586-021-04064-3","article-title":"The power of genetic diversity in genome-wide association studies of lipids","volume":"600","author":"Graham","year":"2021","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117558_bib11","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/s41588-022-01233-6","article-title":"Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants","volume":"54","author":"Aragam","year":"2022","journal-title":"Nat. Genet."},{"issue":"7934","key":"10.1016\/j.atherosclerosis.2024.117558_bib12","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-022-05165-3","article-title":"Stroke genetics informs drug discovery and risk prediction across ancestries","volume":"611","author":"Mishra","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2024.117558_bib13","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","article-title":"Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation","volume":"54","author":"Mahajan","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2024.117558_bib14","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65554","article-title":"Genetic architecture of 11 organ traits derived from abdominal MRI using deep learning","volume":"10","author":"Liu","year":"2021","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117558_bib15","doi-asserted-by":"crossref","first-page":"4571","DOI":"10.1038\/s41467-021-24563-1","article-title":"GWAS of serum ALT and AST reveals an association of SLC30A10 Thr95Ile with hypermanganesemia symptoms","volume":"12","author":"Ward","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2024.117558_bib16","article-title":"Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease","volume":"2","author":"Ghodsian","year":"2021","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117558_bib17","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1038\/s41467-021-24491-0","article-title":"Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals","volume":"12","author":"Stanzick","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117558_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009440","article-title":"A more accurate method for colocalisation analysis allowing for multiple causal variants","volume":"17","author":"Wallace","year":"2021","journal-title":"PLoS Genet."},{"issue":"7944","key":"10.1016\/j.atherosclerosis.2024.117558_bib19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2024.117558_bib20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","article-title":"Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2024.117558_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1010299","article-title":"Fine-mapping from summary data with the \u201csum of single effects\u201d model","volume":"18","author":"Zou","year":"2022","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117558_bib39","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-020-20885-8","article-title":"A fast and efficient colocalization algorithm for identifying shared genetic risk factors across multiple traits","volume":"12","author":"Foley","year":"2021","journal-title":"Nat. Commun."},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2024.117558_bib38","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gky1016","article-title":"CADD: predicting the deleteriousness of variants throughout the human genome","volume":"47","author":"Rentzsch","year":"2019","journal-title":"Nucl. Acids Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117558_bib22","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117558_bib23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants","volume":"40","author":"Pierce","year":"2011","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2024.117558_bib24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-genom-083117-021731","article-title":"Inferring causal relationships between risk factors and outcomes from genome-wide association study data","volume":"19","author":"Burgess","year":"2018","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117558_bib25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmet.2010.11.002","article-title":"Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages","volume":"12","author":"Lichtenstein","year":"2010","journal-title":"Cell Metabol."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2024.117558_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140989","article-title":"Hepatocyte-specific suppression of ANGPTL4 improves obesity-associated diabetes and mitigates atherosclerosis in mice","volume":"131","author":"Singh","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2024.117558_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97918","article-title":"Absence of ANGPTL4 in adipose tissue improves glucose tolerance and attenuates atherogenesis","volume":"3","author":"Aryal","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.atherosclerosis.2024.117558_bib28","series-title":"First-in-human Phase I Trial with Lipigons Lipid-Lowering Candidate Lipisense - Lipigon","author":"Nilsson S","year":"2023"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2024.117558_bib29","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1074\/jbc.RA118.005932","article-title":"Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition","volume":"294","author":"Gutgsell","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2024.117558_bib40","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/eurheartj\/ehaa972","article-title":"Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis","volume":"42","author":"Wang","year":"2021","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2024.117558_bib30","article-title":"Genetic mimicry analysis reveals the specific lipases targeted by the ANGPTL3-ANGPTL8 complex and ANGPTL4","volume":"64","author":"Landfors","year":"2023","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.atherosclerosis.2024.117558_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad845","article-title":"Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk","author":"Gobeil","year":"2024","journal-title":"Eur. Heart J."},{"issue":"9A","key":"10.1016\/j.atherosclerosis.2024.117558_bib32","doi-asserted-by":"crossref","first-page":"22Q","DOI":"10.1016\/S0002-9149(98)00770-X","article-title":"Triglyceride as a risk factor for coronary artery disease","volume":"82","author":"Gotto","year":"1998","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2024.117558_bib33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/ije\/dyaa216","article-title":"High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease","volume":"50","author":"Zuber","year":"2021","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2024.117558_bib34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1001\/jama.2018.20045","article-title":"Association of triglyceride-lowering LPL variants and LDL-C\u2013lowering LDLR variants with risk of coronary heart disease","volume":"321","author":"Ference","year":"2019","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2024.117558_bib35","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1161\/CIRCULATIONAHA.111.067264","article-title":"Body fat distribution and risk of cardiovascular disease","volume":"126","author":"Despr\u00e9s","year":"2012","journal-title":"Circulation"},{"issue":"6509","key":"10.1016\/j.atherosclerosis.2024.117558_bib36","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2024.117558_bib37","series-title":"Lipisense\u00ae Progressing to Phase II - what Comes Next?","author":"Lipigon Pharmaceuticals","year":"2023"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024001187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915024001187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T18:07:40Z","timestamp":1715278060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915024001187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":40,"alternative-id":["S0021915024001187"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117558","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.02.13.24302776","asserted-by":"object"}]},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of loss-of-function in angiopoietin-like 4 on the human phenome","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.117558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117558"}}